Stock Screener App

Frei -

Installieren

0.00

0.00% 0.00

BioLingus (Cayman) Ltd (SUBL)

Überblick Nachrichten Preisverlauf Forum Prognose

BioLingus (Cayman) Ltd Aktie (SUBL) Neueste Nachrichten

BioLingus Company Profile & Introduction - Moomoo

securities and exchange commissionSEC.gov - SEC.gov

Biolingus, oral GLP-1 diabetes drug developer, files for $47M IPO (Pending:SUBL) - Seeking Alpha

ROIV

$30.41

1.27%

MRNA

$55.40

6.27%

BNTX

$89.50

1.43%

RPRX

$54.21

0.11%

ONC

$263.92

1.60%

RVMD

$156.58

2.17%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Offen in Reuters